5-148108804-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_006846.4(SPINK5):​c.1659C>T​(p.Val553Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.537 in 1,610,638 control chromosomes in the GnomAD database, including 236,252 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.60 ( 27940 hom., cov: 31)
Exomes 𝑓: 0.53 ( 208312 hom. )

Consequence

SPINK5
NM_006846.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: 0.0280

Publications

22 publications found
Variant links:
Genes affected
SPINK5 (HGNC:15464): (serine peptidase inhibitor Kazal type 5) This gene encodes a multidomain serine protease inhibitor that contains 15 potential inhibitory domains. The encoded preproprotein is proteolytically processed to generate multiple protein products, which may exhibit unique activities and specificities. These proteins may play a role in skin and hair morphogenesis, as well as anti-inflammatory and antimicrobial protection of mucous epithelia. Mutations in this gene may result in Netherton syndrome, a disorder characterized by ichthyosis, defective cornification, and atopy. This gene is present in a gene cluster on chromosome 5. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
FBXO38-DT (HGNC:55589): (FBXO38 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 5-148108804-C-T is Benign according to our data. Variant chr5-148108804-C-T is described in ClinVar as Benign. ClinVar VariationId is 194856.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.028 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.748 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPINK5NM_006846.4 linkc.1659C>T p.Val553Val synonymous_variant Exon 18 of 33 ENST00000256084.8 NP_006837.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPINK5ENST00000256084.8 linkc.1659C>T p.Val553Val synonymous_variant Exon 18 of 33 1 NM_006846.4 ENSP00000256084.7

Frequencies

GnomAD3 genomes
AF:
0.597
AC:
90622
AN:
151760
Hom.:
27889
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.755
Gnomad AMI
AF:
0.509
Gnomad AMR
AF:
0.641
Gnomad ASJ
AF:
0.466
Gnomad EAS
AF:
0.476
Gnomad SAS
AF:
0.491
Gnomad FIN
AF:
0.536
Gnomad MID
AF:
0.545
Gnomad NFE
AF:
0.526
Gnomad OTH
AF:
0.586
GnomAD2 exomes
AF:
0.559
AC:
137754
AN:
246588
AF XY:
0.548
show subpopulations
Gnomad AFR exome
AF:
0.763
Gnomad AMR exome
AF:
0.727
Gnomad ASJ exome
AF:
0.473
Gnomad EAS exome
AF:
0.475
Gnomad FIN exome
AF:
0.548
Gnomad NFE exome
AF:
0.521
Gnomad OTH exome
AF:
0.544
GnomAD4 exome
AF:
0.530
AC:
773849
AN:
1458760
Hom.:
208312
Cov.:
37
AF XY:
0.527
AC XY:
382570
AN XY:
725634
show subpopulations
African (AFR)
AF:
0.762
AC:
25443
AN:
33374
American (AMR)
AF:
0.715
AC:
31903
AN:
44630
Ashkenazi Jewish (ASJ)
AF:
0.472
AC:
12295
AN:
26040
East Asian (EAS)
AF:
0.446
AC:
17644
AN:
39526
South Asian (SAS)
AF:
0.490
AC:
42248
AN:
86182
European-Finnish (FIN)
AF:
0.547
AC:
29078
AN:
53170
Middle Eastern (MID)
AF:
0.539
AC:
3091
AN:
5740
European-Non Finnish (NFE)
AF:
0.522
AC:
579773
AN:
1109872
Other (OTH)
AF:
0.538
AC:
32374
AN:
60226
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
19101
38202
57302
76403
95504
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16786
33572
50358
67144
83930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.597
AC:
90730
AN:
151878
Hom.:
27940
Cov.:
31
AF XY:
0.597
AC XY:
44309
AN XY:
74228
show subpopulations
African (AFR)
AF:
0.755
AC:
31307
AN:
41440
American (AMR)
AF:
0.641
AC:
9769
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.466
AC:
1616
AN:
3466
East Asian (EAS)
AF:
0.475
AC:
2448
AN:
5150
South Asian (SAS)
AF:
0.493
AC:
2372
AN:
4814
European-Finnish (FIN)
AF:
0.536
AC:
5651
AN:
10546
Middle Eastern (MID)
AF:
0.524
AC:
153
AN:
292
European-Non Finnish (NFE)
AF:
0.526
AC:
35714
AN:
67910
Other (OTH)
AF:
0.588
AC:
1238
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1807
3615
5422
7230
9037
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
748
1496
2244
2992
3740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.552
Hom.:
35823
Bravo
AF:
0.617
Asia WGS
AF:
0.554
AC:
1922
AN:
3476
EpiCase
AF:
0.521
EpiControl
AF:
0.533

ClinVar

Significance: Benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Jan 09, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 89% of patients studied by a panel of primary immunodeficiencies. Number of patients: 78. Only high quality variants are reported. -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Netherton syndrome Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1Other:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

Ichthyosis linearis circumflexa Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
3.1
DANN
Benign
0.65
PhyloP100
0.028
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2303071; hg19: chr5-147488367; COSMIC: COSV56248949; API